Sevelamer Carbonate NDC 87367-266

NDC codes

FDA NDC Directory

Product NDC (as listed)87367-266Labeler and product segments. Claims need a package NDC.

Product NDC at billing width87367-0266Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
87367-266-12	87367026612	270 TABLET, FILM COATED in 1 BOTTLE (87367-266-12)Marketed from May 21, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sevelamer Carbonate
Generic name (nonproprietary): sevelamer carbonate
Active ingredients: Sevelamer carbonate — 800 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: INSIGNAMEDEX LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212970
Marketing start: May 21, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Phosphate Chelating Activity (Mechanism)
Identifiers: Product ID 87367-266_52693574-1205-8244-e063-6394a90a5e78SPL ID 52693574-1205-8244-e063-6394a90a5e78SPL set ID 51ce2ed6-3acf-a6ea-e063-6294a90a21aaRxCUI 749206UNII 9YCX42I8IU
Pharmacologic class: Phosphate Binder

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N487367026612 followed by a unit qualifier and the quantity

Package 87367-0266-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 22, 2026.

Indications (excerpt from the label)

Sevelamer carbonate tablets are indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 212970

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212970
Product	Strength	Form · route	Labeler	Product NDC
Sevelamer Carbonate	Sevelamer carbonate 800 mg/1	Tablet, Film coatedOral	Marp Pharma	85898-101